Back to 
Northern Trust Corp.
Northern Trust Corp.
BCLI
Showing 2 of 24 quarters
Position history for Northern Trust Corp.'s holdings in BRAINSTORM CELL THERAPEUTICS
No. Northern Trust exited its BCLI (Brainstorm Cell Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 112,358 shares worth $25,876. Northern Trust already held BCLI in its Q1 2019 13F, the earliest on record, and held it in 23 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$25,876
Total Shares Change
-112,358
Quarter-by-Quarter History
Other major holders of BCLI: State Street Corp., Geode Capital Management, LLC, Invesco Ltd.